Erbitux and malignant neoplasm progression 
Erbitux and malignant neoplasm progression Patient Reports February 11, 2012
Erbitux Side Effects Report #4638991-6
Erbitux side effect was reported by a Health Professional from on Feb 28, 2005. Male patient, 75 years of age, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, respiratory distress. Erbitux dosage: unknown. During the same period patient was treated with DEXAMETHASONE, DIPHENHYDRAMINE, DURAGESIC, PERCOCET, TAXOL. Patient was hospitalized. Patient died on 02/27/2005.
Erbitux Side Effects Report #5082576-7
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on June 26, 2006. Male patient, 53 years of age, weighting 154.3 lb, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: coma, dyspnoea, malignant neoplasm progression. Erbitux dosage: unknown. During the same period patient was treated with DECADRON, BENADRYL, ACETAMINOPHEN, PREDNISONE, INHALERS, TOPROL. Patient was hospitalized. Patient died on 07/22/2006.
Erbitux Side Effects Report #5001773-X
Erbitux side effect was reported by a Health Professional from GERMANY on Mar 20, 2006. Female patient, 85 years of age, weighting 99.21 lb, was diagnosed with squamous cell carcinoma, hypertension, insomnia and was treated with Erbitux. After drug was administered, patient experienced the following side effects: facial palsy, malignant neoplasm progression. Erbitux dosage: unknown. During the same period patient was treated with CATAPRES, SERESTA. Patient died on 03/05/2006.
Erbitux Side Effects Report #4675767-8
Erbitux side effect was reported by a Consumer or non-health professional from on Apr 12, 2005. Male patient, weighting 138.9 lb, was diagnosed with rectal cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Erbitux dosage: unknown. Patient recovered.
Erbitux Side Effects Report #5040159-9
Erbitux side effect was reported by a Health Professional from GERMANY on June 23, 2006. Male patient, 66 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: ascites, blood creatinine increased, c-reactive protein increased, diabetes mellitus inadequate control, lung infiltration, malignant neoplasm progression, small intestinal obstruction, vomiting. Erbitux dosage: unknown. During the same period patient was treated with OXALIPLATIN, GEMCITABINE, ATENOLOL, DELIX PLUS, RAMIPRIL, PANTOZOL, NOVALGIN, PASPERTIN. Patient was hospitalized. Patient died on 08/15/2005.
Erbitux Side Effects Report #5048025-X
Erbitux side effect was reported by a Health Professional from UNITED STATES on July 10, 2006. Male patient, 65 years of age, weighting 164.2 lb, was diagnosed with pancreatic carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: anorexia, ascites, constipation
, gastrointestinal disorder, gastrointestinal haemorrhage, lung consolidation, malignant neoplasm progression, malignant peritoneal neoplasm, metastases to liver. Erbitux dosage: 400 MG/M2 ONCE IV DRIP; 250 MG/M2 WEEKLY IV DRIP. During the same period patient was treated with CYCLOPHOSPHAMIDE, ALLOGENEIC PANCREATIC CANCER VACCINE. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #5252424-0
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 01, 2006. Male patient, 61 years of age, was diagnosed with pancreatic carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Erbitux dosage: unknown. During the same period patient was treated with OXALIPLATIN, AVASTIN, ATIVAN, BENADRYL, DECADRON, KYTRIL. Patient died on 03/21/2006.
Erbitux Side Effects Report #5161292-7
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 12, 2006. Male patient, 61 years of age, was diagnosed with pancreatic carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Erbitux dosage: unknown. Patient died on 03/21/2006.
Erbitux Side Effects Report #5072773-9
Erbitux side effect was reported by a Health Professional from UNITED STATES on Aug 02, 2006. Female patient, 57 years of age, weighting 116.8 lb, was diagnosed with pancreatic carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: back pain
, chest pain , malignant neoplasm progression, nausea , tachycardia. Erbitux dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, VACCINE. Patient was hospitalized. Patient died on 07/27/2006.Erbitux Side Effects Report #5019833-6
Erbitux side effect was reported by a Health Professional from UNITED STATES on June 05, 2006. Male patient, 57 years of age, weighting 250.0 lb, was diagnosed with pancreatic carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: cerebrovascular accident, malignant neoplasm progression, pancreatic carcinoma. Erbitux dosage: 920 MG WEEKLY IV. During the same period patient was treated with OXYCONTIN, OXYCODONE, AMBIEN, NEXIUM. Patient died on 04/14/2006.
Erbitux Side Effects Report #6131442-4
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on July 28, 2008. Male patient, 65 years of age, was diagnosed with oesophageal carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Erbitux dosage: unknown. Patient died on 05/28/2008.
Erbitux Side Effects Report #5061945-5
Erbitux side effect was reported by a Health Professional from UNITED STATES on Apr 25, 2006. Male patient, 57 years of age, weighting 169.8 lb, was diagnosed with non-small cell lung cancer metastatic, hyperlipidaemia, gastrooesophageal reflux disease, insomnia and was treated with Erbitux. After drug was administered, patient experienced the following side effects: atrial fibrillation
, confusional state, dyspnoea, malignant neoplasm progression. Erbitux dosage: unknown. During the same period patient was treated with PEMETREXED DI, PLAVIX, CARAFATE, RESTORIL, DEXAMETHASONE, ALBUTEROL SPIROS. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #5219318-8
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 22, 2007. Male patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, renal failure, respiratory failure. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL, PREDNISONE, SINGULAIR, NORCO, FELODIPINE, ZOCOR. Patient was hospitalized. Patient died on 12/04/2006.
Erbitux Side Effects Report #5220824-0
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 22, 2007. Male patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, neutropenia, pneumonia
, renal failure, renal failure acute, respiratory failure, sepsis . Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL, PREDNISONE, SINGULAIR, NORCO, FELODIPINE, ZOCOR. Patient was hospitalized. Patient died on 12/04/2006.Erbitux Side Effects Report #5337078-7
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on May 25, 2007. Male patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, renal failure, respiratory failure. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL, PREDNISONE, SINGULAIR, NORCO, FELODIPINE, ZOCOR. Patient was hospitalized. Patient died on 12/04/2006.
Erbitux Side Effects Report #5363812-6
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2007. Male patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, renal failure, respiratory failure. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL, PREDNISONE, SINGULAIR, NORCO, FELODIPINE, ZOCOR. Patient was hospitalized. Patient died on 12/04/2006.
Erbitux Side Effects Report #5367288-4
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2007. Male patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pneumonia
, renal failure, respiratory failure, sepsis . Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL, PREDNISONE, SINGULAIR, NORCO, FELODIPINE, ZOCOR. Patient was hospitalized. Patient died on 12/04/2006.Erbitux Side Effects Report #5072526-1
Erbitux side effect was reported by a Health Professional from UNITED STATES on Aug 03, 2006. Male patient, 72 years of age, weighting 160.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dizziness
, malignant neoplasm progression. Erbitux dosage: unknown. During the same period patient was treated with PEMETREXED DI, FOLIC ACID, TOPROL, VITAMIN B. Patient was hospitalized. Patient died on 07/26/2006.Erbitux Side Effects Report #5379149-5
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on June 29, 2007. Male patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, renal failure, respiratory failure. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL, PREDNISONE, SINGULAIR, NORCO, FELODIPINE, ZOCOR. Patient was hospitalized. Patient died on 12/04/2006.
Erbitux Side Effects Report #5141330-8
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 22, 2006. Male patient, 68 years of age, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: anaemia, electrolyte imbalance, fall
, humerus fracture, hypokalaemia, malignant neoplasm progression, neutropenia, pneumonia . Erbitux dosage: unknown. During the same period patient was treated with TAXOL, CARBOPLATIN, LISINOPRIL, NORVASC, NAPROSYN. Patient was hospitalized. Patient died on 02/21/2006.Erbitux Side Effects Report #5171848-3
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 22, 2006. Male patient, 68 years of age, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: anaemia, electrolyte imbalance, fall
, humerus fracture, hypokalaemia, malignant neoplasm progression, neutropenia, pneumonia . Erbitux dosage: unknown. During the same period patient was treated with TAXOL, CARBOPLATIN, LISINOPRIL, NORVASC, NAPROSYN. Patient was hospitalized. Patient died on 02/21/2006.Erbitux Side Effects Report #4968659-8
Erbitux side effect was reported by a Health Professional from UNITED STATES on Aug 02, 2005. Male patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pneumonia
. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOTERE, NEXIUM, CARDIZEM, PLAVIX, PERCOCET, BUMETANIDE, SINEMET. Patient was hospitalized. Patient died on 06/17/2005.Erbitux Side Effects Report #4997882-1
Erbitux side effect was reported by a Health Professional from UNITED STATES on Sept 22, 2005. Male patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: faecaloma, malignant neoplasm progression, pneumonia
, respiratory failure. Erbitux dosage: INITIAL TX DATE: 31-MAY-05. RECEIVED 480 MG ON 24-OCT-2005.. During the same period patient was treated with CARBOPLATIN, BENADRYL, FENTANYL, PERCOCET, ATENOLOL. Patient was hospitalized. Patient died on 11/05/2005.Erbitux Side Effects Report #4988433-6
Erbitux side effect was reported by a Health Professional from UNITED STATES on Jan 27, 2006. Male patient, 62 years of age, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Erbitux dosage: unknown. During the same period patient was treated with METFORMIN, MS CONTIN, MORPHINE SULPHATE, TRAZODONE, COLACE, FESO. Patient was hospitalized. Patient died on 01/26/2006.
Erbitux Side Effects Report #5076488-2
Erbitux side effect was reported by a Consumer or non-health professional from GERMANY on Feb 09, 2006. Female patient, 61 years of age, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dehydration, malignant neoplasm progression, nausea
, pain . Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN, VINORELBINE, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE, GRANISETRON, DOMPERIDONE, TRAMADOL, CYCLIZINE. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #5046263-3
Erbitux side effect was reported by a Health Professional from UNITED STATES on July 07, 2006. Male patient, 51 years of age, weighting 147.3 lb, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: confusional state, malignant neoplasm progression, metastases to central nervous system, oedema. Erbitux dosage: 250MG/M2, IV WKLY. During the same period patient was treated with ALIMTA. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #4974103-7
Erbitux side effect was reported by a Health Professional from UNITED STATES on Mar 03, 2006. Male patient, 44 years of age, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: agitation, anorexia, body temperature increased, confusional state, haemoglobin decreased, heart rate increased, listless, malignant neoplasm progression, non-small cell lung cancer. Erbitux dosage: unknown. During the same period patient was treated with TAXOL, CARBOPLATIN, TUSSIONEX, LISINOPRIL, LIPITOR. Patient was hospitalized. Patient died on 04/02/2006.
Erbitux Side Effects Report #5607604-9
Erbitux side effect was reported by a Health Professional from UNITED STATES on Jan 28, 2008. Male patient, weighting 179.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: blood culture positive, culture urine positive, hyponatraemia, malignant neoplasm progression, pericardial effusion malignant, renal failure, respiratory failure, sputum culture positive. Erbitux dosage: unknown. During the same period patient was treated with DASATINIB BMS. Patient was hospitalized. Patient died on 01/15/2008.
Erbitux Side Effects Report #5684684-6
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on June 13, 2007. Female patient, 87 years of age, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: disease progression, malignant neoplasm progression, rash
, stomatitis. Erbitux dosage: unknown. During the same period patient was treated with TYLENOL W, MAGIC MOUTHWASH, DIFLUCAN, BIAXIN, NYSTATIN SWISH. Patient died on 09/11/2006.Erbitux Side Effects Report #5684621-4
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on July 11, 2007. Male patient, 75 years of age, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: cardiac arrest
, malignant neoplasm progression. Erbitux dosage: unknown. During the same period patient was treated with BENADRYL, GLUCOTROL, REGLAN, OXYCONTIN, PRILOSEC, RITALIN, SELENIUM, WHEAT GERM. Patient died.Erbitux Side Effects Report #5252485-9
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 13, 2006. Male patient, 64 years of age, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Erbitux dosage: unknown. Patient died.
Erbitux Side Effects Report #5684534-8
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 22, 2007. Male patient, 64 years of age, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: hypopharyngeal cancer, malignant neoplasm progression. Erbitux dosage: DOSING INCLUDED 625 MG LOT#06C00289A, 390 MG LOT# 06C00382B AND 390 MG LOT# 06C00380A. During the same period patient was treated with BENADRYL, TYLENOL, KYTRIL, ARANESP. Patient died on 11/11/2006.
Erbitux Side Effects Report #4594686-9
Erbitux side effect was reported by a Physician from on Dec 22, 2004. Male patient, 58 years of age, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Erbitux dosage: unknown. Patient died on 12/22/2004.
Erbitux Side Effects Report #5012809-4
Erbitux side effect was reported by a Health Professional from UNITED STATES on Mar 20, 2006. Male patient, 44 years of age, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Erbitux dosage: unknown. During the same period patient was treated with BENADRYL, VICODIN, NEURONTIN, AMBIEN, DURAGESIC. Patient died on 06/28/2005.
Erbitux Side Effects Report #5684893-6
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 19, 2007. Female patient, 33 years of age, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Erbitux dosage: unknown. During the same period patient was treated with PROCRIT, CISPLATIN. Patient recovered.
Erbitux Side Effects Report #5099446-0
Erbitux side effect was reported by a Health Professional from UNITED STATES on Sept 01, 2006. Male patient, 76 years of age, weighting 176.4 lb, was diagnosed with multiple myeloma
and was treated with Erbitux. After drug was administered, patient experienced the following side effects: acute myocardial infarction, asthenia, cardiac failure congestive, epistaxis, hypoxia, malignant neoplasm progression, mental impairment. Erbitux dosage: unknown. During the same period patient was treated with DECADRON, ARANESP. Patient was hospitalized. Patient died on 07/19/2006.Erbitux Side Effects Report #5091832-8
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on June 28, 2006. Male patient, 57 years of age, weighting 114.6 lb, was diagnosed with malignant neoplasm progression and was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, respiratory arrest. Erbitux dosage: unknown. During the same period patient was treated with ONCOVIN, PERCOCET. Patient was hospitalized. Patient died on 11/16/2005.
Erbitux Side Effects Report #5695540-1
Erbitux side effect was reported by a Physician from GERMANY on Mar 27, 2008. Male patient, 52 years of age, weighting 121.3 lb, was diagnosed with lung squamous cell carcinoma stage iii, aplasia and was treated with Erbitux. After drug was administered, patient experienced the following side effects: anaemia, dehydration, diarrhoea, febrile neutropenia, hyponatraemia, malignant neoplasm progression, renal failure acute. Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN, ZOPHREN, GRANOCYTE, TAXOTERE. Patient was hospitalized. Patient died on 12/13/2007.
Erbitux Side Effects Report #6036757-6
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 02, 2008. Male patient, 57 years of age, weighting 136.7 lb, was diagnosed with laryngeal cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Erbitux dosage: 1 FORM: 450MG-720MG USUALLY WEEKLY WITH SOME ONE TIME DOSES.. During the same period patient was treated with PACLITAXEL, CISPLATIN, DEXAMETHASONE, ZOFRAN, ONDANSETRON. Patient died.
Erbitux Side Effects Report #4594679-1
Erbitux side effect was reported by a Consumer or non-health professional from on Dec 14, 2004. Female patient, 78 years of age, was diagnosed with colorectal cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dermatitis acneiform, malignant neoplasm progression, paronychia, rash pustular. Erbitux dosage: unknown. Patient died.
Erbitux Side Effects Report #5068147-7
Erbitux side effect was reported by a Health Professional from UNITED STATES on Apr 26, 2005. Male patient, 76 years of age, was diagnosed with colorectal cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: ascites, malignant neoplasm progression, pleural effusion, respiratory failure. Erbitux dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient died on 04/24/2005.
Erbitux Side Effects Report #5074179-5
Erbitux side effect was reported by a Health Professional from UNITED STATES on Apr 26, 2005. Male patient, 76 years of age, was diagnosed with colorectal cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: ascites, malignant neoplasm progression, respiratory failure. Erbitux dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient died on 04/24/2005.
Erbitux Side Effects Report #5078215-1
Erbitux side effect was reported by a Health Professional from UNITED STATES on Apr 26, 2005. Male patient, 76 years of age, was diagnosed with colorectal cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: ascites, malignant neoplasm progression, respiratory failure. Erbitux dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient died on 04/24/2005.
Erbitux Side Effects Report #5109357-X
Erbitux side effect was reported by a Health Professional from UNITED STATES on Apr 26, 2005. Male patient, 76 years of age, was diagnosed with colorectal cancer metastatic, abdominal pain
, constipation and was treated with Erbitux. After drug was administered, patient experienced the following side effects: anorexia, ascites, constipation , dehydration, malignant neoplasm progression, pleural effusion, pyrexia, respiratory failure, small intestinal obstruction. Erbitux dosage: unknown. During the same period patient was treated with IRINOTECAN, OXYCONTIN, RANITIDINE, PROCHLORPERAZINE, MIRALAX, ALTACE, TOPROL. Patient was hospitalized. Patient died on 04/24/2005.Erbitux Side Effects Report #5118811-6
Erbitux side effect was reported by a Health Professional from UNITED STATES on Apr 26, 2005. Male patient, 76 years of age, was diagnosed with colorectal cancer metastatic, abdominal pain
, constipation and was treated with Erbitux. After drug was administered, patient experienced the following side effects: ascites, malignant neoplasm progression, pleural effusion, pyrexia, respiratory failure, small intestinal obstruction. Erbitux dosage: unknown. During the same period patient was treated with IRINOTECAN, MORPHINE, LEVOFLOXACIN, OXYCONTIN, OXYCODONE, RANITIDINE, PROCHLORPERAZINE, MIRALAX. Patient was hospitalized. Patient died on 04/24/2005.Erbitux Side Effects Report #5814379-7
Erbitux side effect was reported by a Consumer or non-health professional from AUSTRALIA on July 15, 2008. Male patient, 76 years of age, was diagnosed with colorectal cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: interstitial lung disease, malignant neoplasm progression, pneumonia
. Erbitux dosage: unknown. Patient was hospitalized. Patient died on 04/07/2008.Erbitux Side Effects Report #4940876-2
Erbitux side effect was reported by a Physician from GERMANY on Mar 01, 2006. Female patient, 76 years of age, was diagnosed with colorectal cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: hypertrichosis, malignant neoplasm progression. Erbitux dosage: unknown. During the same period patient was treated with ELOXATIN, XELODA. Patient died on 11/01/2005.
Erbitux Side Effects Report #5068149-0
Erbitux side effect was reported by a Health Professional from UNITED STATES on Feb 16, 2005. Male patient, 72 years of age, was diagnosed with colorectal cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Erbitux dosage: 495 TO 792 MG. HAS BEEN DOSE-ESCALATED TO 400 MG/M2 X 2 TREATMENTS.. Patient was hospitalized. Patient died on 03/11/2005.
Erbitux Side Effects Report #5038576-6
Erbitux side effect was reported by a Health Professional from GERMANY on June 19, 2006. Male patient, 70 years of age, was diagnosed with colorectal cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea, lower respiratory tract infection, malignant neoplasm progression. Erbitux dosage: unknown. During the same period patient was treated with IRINOTECAN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5300263-4
Erbitux side effect was reported by a Physician from JAPAN on Apr 11, 2007. Male patient, 68 years of age, weighting 191.8 lb, was diagnosed with colorectal cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: diarrhoea, febrile neutropenia, malignant neoplasm progression, septic shock. Erbitux dosage: unknown. During the same period patient was treated with CAMPTOSAR. Patient was hospitalized. Patient died on 04/02/2007.
Erbitux Side Effects Report #5040846-2
Erbitux side effect was reported by a Consumer or non-health professional from CANADA on Feb 21, 2005. Male patient, 65 years of age, weighting 253.5 lb, was diagnosed with colorectal cancer metastatic, hypertension, sedation, rash
and was treated with Erbitux. After drug was administered, patient experienced the following side effects: asthenia, dyspnoea, haemoglobin decreased, hypoalbuminaemia, hypocalcaemia, hypomagnesaemia, malignant neoplasm progression. Erbitux dosage: unknown. During the same period patient was treated with METOPROLOL TARTRATE, ALTACE, ZOPICLONE, POLYSPORIN. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #4962919-2
Erbitux side effect was reported by a Health Professional from UNITED KINGDOM on Dec 28, 2005. Male patient, 65 years of age, was diagnosed with colorectal cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: bile duct stenosis, cardiac failure, cholangitis, jaundice cholestatic, lipase increased, malignant neoplasm progression. Erbitux dosage: unknown. During the same period patient was treated with IRINOTECAN, TROPISETRON, ATROPINE, TAVEGIL, FUROSEMIDE, HYDROCHLOROTHIAZIDE, CILAZAPRIL, THIAMAZOLE. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5161183-1
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 04, 2006. Male patient, 61 years of age, was diagnosed with colorectal cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Erbitux dosage: unknown. During the same period patient was treated with XELODA. Patient died.
Erbitux Side Effects Report #5971471-4
Erbitux side effect was reported by a Health Professional from GERMANY on Nov 19, 2008. Male patient, 61 years of age, was diagnosed with colorectal cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: convulsion, infusion related reaction, malignant neoplasm progression. Erbitux dosage: unknown. During the same period patient was treated with FLUOROURACIL, CAMPTOSAR, LEUCOVORIN CALCIUM, VERAPAMIL, PRAVASTATIN, DEXTROPROPOXYPHENE, ALLOPURINOL. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #4817071-0
Erbitux side effect was reported by a Physician from UNITED STATES on Sept 13, 2005. Male patient, 59 years of age, was diagnosed with colorectal cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Erbitux dosage: INITIAL TX OF 780 MG ON 01-JUL-05. THEN 490 MG ON 15-JUL, 22-JUL AND 29-JUL-05.. Patient died.
Erbitux Side Effects Report #4840522-2
Erbitux side effect was reported by a Physician from UNITED STATES on Sept 13, 2005. Male patient, 59 years of age, was diagnosed with colorectal cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Erbitux dosage: INITIAL TX OF 780 MG ON 01-JUL-05. THEN 490 MG ON 15-JUL, 22-JUL AND 29-JUL-05.. Patient died.
Erbitux Side Effects Report #5047970-9
Erbitux side effect was reported by a Consumer or non-health professional from CANADA on Feb 03, 2005. Female patient, 58 years of age, weighting 123.5 lb, was diagnosed with colorectal cancer metastatic, cough, hypertension, hypercholesterolaemia and was treated with Erbitux. After drug was administered, patient experienced the following side effects: fatigue, malignant neoplasm progression, tachycardia. Erbitux dosage: INITIATED ON 26-OCT-04 (LD=600MG). D/C STUDY ON 23-NOV-04. PT REC'D 2 DOSES.. During the same period patient was treated with LEVOFLOXACIN, FOSINOPRIL, RENEDIL, ATORVASTATIN CALCIUM. Patient was hospitalized. Patient died on 11/30/2004.
Erbitux Side Effects Report #5035448-8
Erbitux side effect was reported by a Consumer or non-health professional from CANADA on Feb 03, 2005. Female patient, 58 years of age, weighting 123.5 lb, was diagnosed with colorectal cancer metastatic, cough, hypertension, hypercholesterolaemia and was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Erbitux dosage: INITIATED ON 26-OCT-04 (LD=600MG). D/C STUDY ON 23-NOV-04. PT REC'D 2 DOSES.. During the same period patient was treated with LEVOFLOXACIN, FOSINOPRIL, RENEDIL, ATORVASTATIN CALCIUM. Patient died on 11/30/2004.
Erbitux Side Effects Report #5029713-8
Erbitux side effect was reported by a Consumer or non-health professional from CANADA on Feb 10, 2005. Male patient, 57 years of age, weighting 178.6 lb, was diagnosed with colorectal cancer metastatic, deep vein thrombosis
, pain and was treated with Erbitux. After drug was administered, patient experienced the following side effects: diarrhoea, fatigue, haematemesis, haemoglobin decreased, malignant neoplasm progression, metastases to abdominal cavity, metastases to liver, upper gastrointestinal haemorrhage. Erbitux dosage: FIRST CETUXIMAB INFUSION ADMINISTERED ON 30-DEC-2004 (750 MG IV ONCE). CETUXIMAB INTERRUPTED.. During the same period patient was treated with COUMADIN, PERCOCET. Patient was hospitalized. Patient died on 02/25/2005.Erbitux Side Effects Report #5065883-3
Erbitux side effect was reported by a Consumer or non-health professional from GERMANY on May 05, 2006. Male patient, 56 years of age, was diagnosed with colorectal cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: blast crisis in myelogenous leukaemia, chromosome analysis abnormal, chronic myeloid leukaemia, malignant neoplasm progression, metastases to lung. Erbitux dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient recovered.
Erbitux Side Effects Report #4619508-9
Erbitux side effect was reported by a Consumer or non-health professional from on Mar 16, 2005. Female patient, 56 years of age, was diagnosed with colorectal cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: colorectal cancer metastatic, hydronephrosis, malignant neoplasm progression, pain
. Erbitux dosage: unknown. During the same period patient was treated with DIPHENHYDRAMINE, DEXAMETHASONE, IRINOTECAN. Patient was hospitalized. Patient died on 02/23/2005.Erbitux Side Effects Report #4638997-7
Erbitux side effect was reported by a Consumer or non-health professional from on Mar 16, 2005. Female patient, 56 years of age, was diagnosed with colorectal cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: hydronephrosis, malignant neoplasm progression, pain
. Erbitux dosage: unknown. During the same period patient was treated with DIPHENHYDRAMINE, DEXAMETHASONE, IRINOTECAN. Patient was hospitalized. Patient died on 02/23/2005.Erbitux Side Effects Report #5072104-4
Erbitux side effect was reported by a Health Professional from UNITED STATES on May 10, 2005. Female patient, 50 years of age, was diagnosed with colorectal cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dehydration, dyspnoea, malignant neoplasm progression. Erbitux dosage: COURSE 2. START DATE 15-MAR-05 (756 MG), 22-MAR TO 19-APR (473MGX5), 26-APR TO 03-MAY-05 (458MG). During the same period patient was treated with VERAPAMIL, THEOPHYLLINE, LORATADINE, ZAFIRLUKAST, SEREVENT, FLUTICASONE PROPIONATE. Patient was hospitalized. Patient died on 06/21/2005.
Erbitux Side Effects Report #4675679-X
Erbitux side effect was reported by a Consumer or non-health professional from on June 02, 2004. Female patient, 42 years of age, weighting 110.2 lb, was diagnosed with colorectal cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: abdominal discomfort, acne
, malignant neoplasm progression, rash , rash macular, rash papular, rash pustular. Erbitux dosage: unknown. During the same period patient was treated with IRINOTECAN, KYTRIL, DECADRON, PHENERGAN. Patient recovered.Erbitux Side Effects Report #5050729-X
Erbitux side effect was reported by a Health Professional from HONG KONG on July 12, 2005. Male patient, 34 years of age, was diagnosed with colorectal cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: hypersensitivity, lung infiltration, malignant neoplasm progression. Erbitux dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient died on 07/18/2005.
Erbitux Side Effects Report #5077033-8
Erbitux side effect was reported by a Health Professional from UNITED STATES on July 16, 2004. Male patient, 76 years of age, was diagnosed with colorectal cancer
, colorectal cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: diarrhoea, malignant neoplasm progression, neutropenia, thrombocytopenia. Erbitux dosage: unknown. During the same period patient was treated with IRINOTECAN, ALDACTONE, LASIX. Patient was hospitalized. Patient died on 07/30/2004.Erbitux Side Effects Report #5084389-9
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on July 26, 2006. Female patient, 63 years of age, was diagnosed with colorectal cancer
and was treated with Erbitux. After drug was administered, patient experienced the following side effects: electrolyte imbalance, malignant neoplasm progression, nausea . Erbitux dosage: unknown. During the same period patient was treated with BENADRYL, DECADRON, ZANTAC. Patient died on 05/12/2006.Erbitux Side Effects Report #5118023-6
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on July 26, 2006. Female patient, 63 years of age, was diagnosed with colorectal cancer
and was treated with Erbitux. After drug was administered, patient experienced the following side effects: electrolyte imbalance, malignant neoplasm progression, nausea . Erbitux dosage: unknown. During the same period patient was treated with BENADRYL, DECADRON, ZANTAC. Patient died on 05/12/2006.Erbitux Side Effects Report #4755856-X
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on June 01, 2005. Female patient, 48 years of age, was diagnosed with colorectal cancer
and was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, rash . Erbitux dosage: unknown. Patient died on 04/05/2005.Erbitux Side Effects Report #4592803-8
Erbitux side effect was reported by a Consumer or non-health professional from on Jan 03, 2005. Male patient, 57 years of age, weighting 176.4 lb, was diagnosed with colon cancer stage iv and was treated with Erbitux. After drug was administered, patient experienced the following side effects: blood bilirubin increased, cholelithiasis, malignant neoplasm progression. Erbitux dosage: 13-SEP-2004LOADDOSE 800 MG;WEEKLY DOSE 500 MG;INTER.25-OCT-2004;RESUMED 20-DEC-2004/D'CD 03-JAN-2005. During the same period patient was treated with ANZEMET, BENADRYL, DEXAMETHASONE, LEVSIN PB, ZANTAC, ATENOLOL, CAMPTOSAR, IMODIUM. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #4597353-0
Erbitux side effect was reported by a Health Professional from on Feb 25, 2005. Male patient, 77 years of age, was diagnosed with colon cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: ascites, malignant neoplasm progression, oedema peripheral, rash
. Erbitux dosage: unknown. During the same period patient was treated with BENADRYL, DECADRON, TAGAMET, ACTOS, AMARYL, ASPIRIN, ISORBIDE, LASIX. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #5677423-6
Erbitux side effect was reported by a Physician from UNITED STATES on Mar 19, 2008. Male patient, 62 years of age, was diagnosed with colon cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: colon cancer, malignant neoplasm progression. Erbitux dosage: unknown. During the same period patient was treated with CAMPTOSAR, PRILOSEC, SYNTHROID, LOPRESSOR, HYDROCHLOROTHIAZIDE, LOVENOX, PLAVIX, ASPIRIN. Patient died on 12/23/2007.
Erbitux Side Effects Report #5161265-4
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 26, 2006. Female patient, 59 years of age, weighting 178.6 lb, was diagnosed with colon cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Erbitux dosage: unknown. During the same period patient was treated with CAMPTOSAR. Patient died on 10/06/2006.
Erbitux Side Effects Report #5808654-X
Erbitux side effect was reported by a Health Professional from GERMANY on July 04, 2008. Male patient, 59 years of age, was diagnosed with colon cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: facial palsy, herpes zoster, malignant neoplasm progression. Erbitux dosage: unknown. During the same period patient was treated with FLUOROURACIL, CAMPTOSAR. Patient was hospitalized and became disabled. Patient recovered.
Erbitux Side Effects Report #4931691-4
Erbitux side effect was reported by a Physician from UNITED STATES on Dec 20, 2005. Female patient, 56 years of age, was diagnosed with colon cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: blepharitis, malignant neoplasm progression. Erbitux dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient died on 07/01/2005.
Erbitux Side Effects Report #5038570-5
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on May 24, 2006. Male patient, 55 years of age, weighting 127.9 lb, was diagnosed with colon cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Erbitux dosage: unknown. During the same period patient was treated with CAMPTOSAR, BENADRYL. Patient died on 05/11/2006.
Erbitux Side Effects Report #4640404-5
Erbitux side effect was reported by a Physician from on Mar 11, 2005. Male patient, 51 years of age, was diagnosed with colon cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: encephalopathy, hepatic encephalopathy, hepatic failure, malignant neoplasm progression. Erbitux dosage: unknown. Patient died on 09/25/2004.
Erbitux Side Effects Report #5087726-4
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on July 13, 2006. Male patient, 42 years of age, weighting 130.1 lb, was diagnosed with colon cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: infusion related reaction, malignant neoplasm progression. Erbitux dosage: unknown. During the same period patient was treated with BENADRYL, DECADRON, ATROPINE, ALOXI, CAMPTOSAR, FOLIC ACID, PHENERGAN, KLONOPIN. Patient was hospitalized. Patient died on 03/23/2006.
Erbitux Side Effects Report #5684581-6
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 12, 2007. Male patient, weighting 211.6 lb, was diagnosed with colon cancer metastatic, pain
and was treated with Erbitux. After drug was administered, patient experienced the following side effects: colon cancer metastatic, malignant neoplasm progression. Erbitux dosage: unknown. During the same period patient was treated with MORPHINE SULPHATE, PREDNISONE, COMPAZINE, ATIVAN, PROCRIT, ZOMETA. Patient died on 01/27/2007.Erbitux Side Effects Report #5076026-4
Erbitux side effect was reported by a Health Professional from UNITED STATES on Aug 08, 2006. Female patient, 65 years of age, weighting 131.0 lb, was diagnosed with colon cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: abdominal pain
, colon cancer metastatic, haematuria, hydronephrosis, malignant neoplasm progression, pelvic mass. Erbitux dosage: 680 MG IV (LOADING DOSE) , 425 MG IV. During the same period patient was treated with CELEBREX, NEURONTIN, LORTAB, PREVACID, HYDROCHLOROTHIAZIDE, VIT B, ENALAPRIL MALEATE. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #4594671-7
Erbitux side effect was reported by a Consumer or non-health professional from on Dec 09, 2004. Male patient, 64 years of age, was diagnosed with colon cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: colon cancer, malignant neoplasm progression, metastases to liver. Erbitux dosage: unknown. Patient died on 12/09/2004.
Erbitux Side Effects Report #6131390-X
Erbitux side effect was reported by a Health Professional from UNITED STATES on May 12, 2008. Male patient, 55 years of age, was diagnosed with colon cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Erbitux dosage: unknown. Patient recovered.
Erbitux Side Effects Report #4931653-7
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 07, 2005. Female patient, 54 years of age, was diagnosed with colon cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Erbitux dosage: unknown. Patient died on 11/04/2005.
Erbitux Side Effects Report #5076021-5
Erbitux side effect was reported by a Health Professional from UNITED STATES on Aug 08, 2006. Female patient, weighting 101.0 lb, was diagnosed with brain cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: breast cancer metastatic, loss of consciousness, malignant neoplasm progression. Erbitux dosage: 365 MG Q WK IV. During the same period patient was treated with CARBOPLATIN. Patient died on 08/02/2006.
Erbitux Side Effects Report #5306119-5
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 28, 2007. Male patient, 58 years of age, was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Erbitux dosage: unknown. During the same period patient was treated with TAXOL, PARAPLATIN. Patient died on 06/24/2006.
Erbitux Side Effects Report #5012849-5
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 25, 2006. Male patient, 48 years of age, weighting 136.7 lb, was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Erbitux dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE, HYDROCODONE, POTASSIUM, DEXAMETHASONE. Patient was hospitalized. Patient died on 01/04/2006.
Erbitux Side Effects Report #6131383-2
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on May 22, 2008. Male patient, 44 years of age, was treated with Erbitux. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Erbitux dosage: unknown. During the same period patient was treated with DARBEPOETIN ALFA, PEGFILGRASTIM. Patient died on 05/02/2008.
Erbitux Side Effects Report #5940686-3
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 03, 2008. Male patient, weighting 172.0 lb, was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspnoea, malignant neoplasm progression, neuropathy peripheral, oesophageal adenocarcinoma metastatic, rash
, respiratory failure. Erbitux dosage: 400 MG. During the same period patient was treated with ELLENCE, FLUOROURACIL, CISPLATIN. Patient was hospitalized. Patient recovered.